Central venous line disconnections with associated blood loss.
In 1996, a product trial was undertaken at Sydney Children's Hospital in response to an increasing number of central venous line disconnections associated with significant blood loss in small children. The product trialled was an extension line containing a one-way valve system with two side ports for needleless access--product code BC595, distributed by REM Systems. This product was chosen from a limited market for the compact size of the valve; this was important as it was to be secured onto the skin surface. It appeared that this product would prevent blood loss in the event of a line disconnection.